We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
E-Riser is an innovative product that is designed to deliver energy efficient homes to the market. The E-Riser is expected to use a third of the energy conventional houses use and it's aim is to make energy efficient houses more affordable for all.
days to go: Expired investment: £52,200
Fullgreen offers a range of 100% plant-based products that are low-carb and preservative-free alternatives for people looking to eat fewer carbohydrates, add more vegetables to their meals, or manage health issues such as obesity and diabetes. Fullgreen also claims that its products are shelf-stable negating the need to refrigerate. The company's catalogue includes non-Genetically Modified Organism (GMO) riced veggies, cauliflower risottos, and oat free plant-based breakfast meals, to name a few. Fullgreen points out that its products are listed in over 9,000 UK and US retailers. The company has dedicated production lines in the UK and US with a capacity of over 18 million pouches per annum. It has sold over 12 million pouches to date and earned £5.4 million in 2020. Fullgreen will use the investment to improve in-store promotions and activations, develop sampling activities for its target consumers, and boost geotargeted advertising and other digital marketing activities.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £752,246
A digital estate agency comprised of three companies (Emoov, Urban and Tepilo) now into one brand in the online and hybrid sector. Emoov is the second largest business in its market with numerous awards and more than 2,000 mentions across various media outlets. Their centralised team oversee a property's valuation and transactions, so the customer doesn’t need to.
days to go: Expired investment: £1,527,130
PLAYin CHOC is an innovative, premium and award-winning manufacturer of vegan organic eco-friendly toys and chocolates. Its products are allergen-free, plastic-free, 100% organic and inspire creative play. Since its launch, PLAYin CHOC has sold approximately 50,000+ units in 21 countries. Additionally, potential stockists for its products are estimated at 100,000 in the UK and 1 million globally. Now, PLAYin CHOC is planning to take its product to the market via high-end food supermarkets; independent food, confectionary and gift shops; travel retail market; direct to the consumer via subscription; and international distributors. Funds raised will be used to increase growth by securing larger and permanent premises and intensify targeted marketing at trade & consumer shows and online.
days to go: Expired investment: £278,450
Selling fashion brands' overstock directly to customers at a lower price as a form of ethical recycling. BlackBetty purchases excess inventory from big brands and pay less than the manufacturing cost of the product. The company does not state the brand name on their website, to prevent damage to the brand. In November 2018, more than 17,000 orders were placed, which was worth over £284k. BlackBetty has seen customers return to the website on average 7 times within the first year to make purchases.
days to go: Expired investment: £289,420
Improving the railway construction industry by collecting data to reduce inefficiencies and overspending. Rail Diary is a B2B SaaS product that is designed to analyse information on infrastructure projects to improve particular elements that plague the industry. These include the delivery, commercialisation and the health and safety of projects. Rail Diary allows developers to monitor ongoing costs, forecast for the future and reduce the number of claims made. Rail Diary will generate revenue via a monthly subscription model ranging from £45 to £150, plus project fees.
days to go: Expired investment: £50,544
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph